References
Maruyama K, Kunikata H, Sugita S, Mochizuki M, Ichinohasama R, Nakazawa T (2015) First case of primary intraocular natural killer t-cell lymphoma. BMC Ophthalmol 15:169
Abedi F, Borovik AM, Waring D, Hariz S, Francis IC (2019) Primary intraocular natural killer/T-cell lymphoma unmasked with infective endophthalmitis after an intravitreal injection of bevacizumab. Clin Exp Ophthalmol:1–2
Tagawa Y, Namba K, Ogasawara R, Kanno H, Ishida S (2015) A case of mature natural killer-cell neoplasm manifesting multiple choroidal lesions: primary intraocular natural killer-cell lymphoma. Case Rep Ophthalmol 6:380–384
Sagoo MS, Mehta H, Swampillai AJ, Cohen VM, Amin SZ, Plowman PN, Lightman S (2014) Primary intraocular lymphoma. Surv Ophthalmol 59:503–516
Egashira M, Kawamata N, Sugimoto K, Kaneko T, Oshimi K (1999) P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. Blood 93:599–606
Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, Ishizawa K, Maseki N, Itoh K, Usui N, Wasada I, Kinoshita T, Ohshima K, Matsuno Y, Terauchi T, Nawano S, Ishikura S, Kagami Y, Hotta T, Oshimi K (2009) Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol 27:5594–5600
Teckie S, Yahalom J (2014) Primary intraocular lymphoma: treatment outcomes with ocular radiation therapy alone. Leuk Lymphoma 55:795–801
Shenkier TN, Blay J-Y, O’Neill BP, Poortmans P, Thiel E, Jahnke K, Abrey LE, Neuwelt E, Tsang R, Batchelor T, Harris N, Ferreri AJ, Ponzoni M, O’Brien P, Rubenstein J, Connors JM (2005) Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group. J Clin Oncol 23:2233–2239
Yamaguchi M, Kwong Y-L, Kim WS, Maeda Y, Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, Suzumiya J, Kodama T, Kimura H, Hyo R, Nakamura S, Oshimi K, Suzuki R (2011) Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 29:4410–4416
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in this report were in accordance with ethical standards of our institute and with the 1964 Helsinki declaration and its later amendments.
Informed consent
Informed consent was obtained from the patient described.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Takimoto-Shimomura, T., Shimura, Y., Nagata, K. et al. Primary intraocular natural killer-cell lymphoma successfully treated using a multidisciplinary strategy. Ann Hematol 98, 2617–2619 (2019). https://doi.org/10.1007/s00277-019-03807-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-019-03807-7